William Phelan
Nessuna posizione attualmente
Patrimonio netto: 1 M $ in data 31/05/2024
Profilo
William L.
Phelan worked as the Chief Accounting Officer & Senior Vice President at MiMedx Group, Inc. from 2020 to 2023.
Prior to that, he worked as the Chief Accounting Officer & Vice President at Sancilio Pharmaceuticals Co., Inc. Mr. Phelan holds an MBA from The Pennsylvania State University and an undergraduate degree from Shippensburg University of Pennsylvania.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
MIMEDX GROUP, INC.
0.12% | 10/05/2023 | 184 219 ( 0.12% ) | 1 M $ | 31/05/2024 |
Precedenti posizioni note di William Phelan
| Società | Posizione | Fine |
|---|---|---|
| MIMEDX GROUP, INC. | Comptroller/Controller/Auditor | 01/09/2023 |
Sancilio Pharmaceuticals Co., Inc.
 Sancilio Pharmaceuticals Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio Pharmaceuticals Co. engaged in the development and manufacture of pharmaceutical products. Its product platform, advanced lipid technologies, focuses on the treatment of diseases and disorders related to lipids such as sickle cell, short bowel, severe hypertriglyceridemia and non-alcoholic fatty liver. The company was founded by Frederick Sancilio in October 2004 and was headquartered in Riviera Beach, FL. | Comptroller/Controller/Auditor | - |
Formazione di William Phelan
| Shippensburg University of Pennsylvania | Undergraduate Degree |
| The Pennsylvania State University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MIMEDX GROUP, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Sancilio Pharmaceuticals Co., Inc.
Sancilio Pharmaceuticals Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio Pharmaceuticals Co. engaged in the development and manufacture of pharmaceutical products. Its product platform, advanced lipid technologies, focuses on the treatment of diseases and disorders related to lipids such as sickle cell, short bowel, severe hypertriglyceridemia and non-alcoholic fatty liver. The company was founded by Frederick Sancilio in October 2004 and was headquartered in Riviera Beach, FL. | Commercial Services |
- Borsa valori
- Insiders
- William Phelan
